WO2000047280A1 - Dispositif a rayonnement a super-hautes frequences et utilisation therapeutique de ce dispositif - Google Patents

Dispositif a rayonnement a super-hautes frequences et utilisation therapeutique de ce dispositif Download PDF

Info

Publication number
WO2000047280A1
WO2000047280A1 PCT/RU2000/000047 RU0000047W WO0047280A1 WO 2000047280 A1 WO2000047280 A1 WO 2000047280A1 RU 0000047 W RU0000047 W RU 0000047W WO 0047280 A1 WO0047280 A1 WO 0047280A1
Authority
WO
WIPO (PCT)
Prior art keywords
treatment
generators
radiation
ghz
range
Prior art date
Application number
PCT/RU2000/000047
Other languages
English (en)
Russian (ru)
Inventor
Vitaly Maximovich Melnikov
Anatoly Vasilevich Usachev
Sergei Dmitrievich Ogurtsov
Vladimir Vitalievich Melnikov
Elena Vladimirovna Dvoryadkina
Original Assignee
Vitaly Maximovich Melnikov
Anatoly Vasilevich Usachev
Sergei Dmitrievich Ogurtsov
Vladimir Vitalievich Melnikov
Elena Vladimirovna Dvoryadkina
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from RU99102300A external-priority patent/RU2139114C1/ru
Application filed by Vitaly Maximovich Melnikov, Anatoly Vasilevich Usachev, Sergei Dmitrievich Ogurtsov, Vladimir Vitalievich Melnikov, Elena Vladimirovna Dvoryadkina filed Critical Vitaly Maximovich Melnikov
Priority to AU31998/00A priority Critical patent/AU3199800A/en
Publication of WO2000047280A1 publication Critical patent/WO2000047280A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/02—Radiation therapy using microwaves

Definitions

  • n ⁇ v ⁇ b ⁇ az ⁇ vany vi ⁇ usny ⁇ and ba ⁇ e ⁇ ialny ⁇ zab ⁇ levany is ⁇ lzue ⁇ sya a ⁇ a ⁇ a ⁇ Ya ⁇ a-3 dia ⁇ az ⁇ ne chas ⁇ 915 ⁇ Gts for na ⁇ uzhn ⁇ g ⁇ ⁇ blucheniya ⁇ l ⁇ n ⁇ s ⁇ yu ⁇ a m ⁇ schn ⁇ s ⁇ i 0,5 -.
  • the device contains antennas associated with individual generators, each of which has a separate radiation range.
  • the “Polna-2 ⁇ ” device is used at a frequency of 460 Hz, with a power of 100 watts.
  • Chemotherapy does not exclude the occurrence of relapses, is characterized by the presence of numerous indications, which are limited to them.
  • antibiotic therapy is not always effective, it leads to the emergence of a gnomey, long non-healing process.
  • Symmetry is in the process of interruption; ascha ⁇ elnymi s ⁇ e ⁇ ami ⁇ ⁇ syam v ⁇ ascheniya.
  • gene ⁇ i ⁇ uemy ⁇ claimed us ⁇ ys ⁇ v ⁇ m, ⁇ ez ⁇ nansny ⁇ ⁇ ⁇ n ⁇ sheniyu ⁇ e ⁇ im ⁇ van ⁇ vym s ⁇ s ⁇ yaniyam ⁇ iv ⁇ di ⁇ ⁇ ischezn ⁇ veniyu magni ⁇ n ⁇ g ⁇ m ⁇ men ⁇ a.
  • the speakers will be damaged if they are damaged.
  • ⁇ liniches ⁇ ie is ⁇ y ⁇ aniya us ⁇ ys ⁇ va radiation S ⁇ CH and s ⁇ s ⁇ ba eg ⁇ lechebn ⁇ g ⁇ is ⁇ lz ⁇ vaniya ⁇ v ⁇ dilis in ⁇ blas ⁇ n ⁇ m ⁇ liniches ⁇ m ⁇ n ⁇ l ⁇ giches ⁇ m dis ⁇ anse ⁇ e in ⁇ editsins ⁇ m ⁇ adi ⁇ l ⁇ giches ⁇ m nauchn ⁇ m tsen ⁇ e in G ⁇ ds ⁇ y ⁇ liniches ⁇ y b ⁇ lnitse, ⁇ II ⁇ n ⁇ l ⁇ gii.
  • the claimed method more than two hundred localized patients were afflicted with more malignant diseases.
  • an analysis of the circumstance is performed, which indicates that the patient is diagnosed with a disease and the condition of the patient.
  • ⁇ ig. 1 shows a general diagram of the devices, in fig. 2.3 its options. on ⁇ ig. 4 versions of the antenna.
  • Each of the generators 2 has its own power supply 7.
  • Each of the generators 2 has its own frequency, and the whole house is free of charge. Density of the ground in the area of the industry. for example, less than 10 mK ⁇ / cm 2 .
  • Each subsequent generator has an increasing frequency range.
  • the device is now operated in the investigative, parallel, mixed and scanning mode.
  • the operating mode of each generator and the device is generally set by the program. DEVICES MAY BE PERFORMED IN VARIOUS OPTIONS:
  • the power source makes up the second unit, connected to the first external cable (external option);
  • the device can be made up of a set of interchangeable units, including generators, antennas and devices.
  • the declared generatrix is divided into “ ⁇ ” diameters. Emissions from the emitted parts are carried out through the antennas (1,3), and with this, the quantitatively disposed of devices are subject to non-hazardous devices.
  • the radiated antenna power is limited to sanitary and hygienic standards for the population and the servicing community.
  • Each generator is controlled by a separate control unit (2), which makes it possible to select a frequency, change the frequency, change the frequency, and switch off the frequency.
  • the operation mode of the ⁇ - ⁇ operation is performed from the computer (EH) (5), with the help of which the functions of the ⁇ are maintained.
  • EH computer
  • a patient may be provided with dozens of centimeters for a few equipment and are only allocated for the size of the chamber and the capacity of the device.
  • the use of a different antenna (Fig. 4) when one generates two antennas is useful for a 8-18 GHz generator for the treatment of pain. having multiple metastases.
  • the mechanism of exposure to RF radiation in the treatment of the claimed device is as follows.
  • the target of the impact of RF radiation is simple non-organic molecules that are binders between biopolymers, which are involved in the biological function of dissociation.
  • the receivers of the relevant frequencies, which are subject to the claimed device. are quantum transitions of these molecules. By choosing the values of these frequencies, it is possible to change the level of dissociation and the strength of the chemical bond in the form of a magnetic moment of binding, so that the magnetic moment disappears and disconnects if it is disconnected.
  • the value of the resonance frequency is chosen for the treatment of portable tissues and does not affect the health of the tissue.
  • patients can be prescribed medications for the treatment of related diseases.
  • the invention is explained by clinical trials.
  • Example 2 Bolnoy B., 58 years. P ⁇ s ⁇ u ⁇ il in ⁇ e ⁇ a ⁇ ev ⁇ iches ⁇ e ⁇ delenie with diagn ⁇ z ⁇ m two- ⁇ s ⁇ nnyaya ⁇ nevm ⁇ niya. Zhal ⁇ by on ⁇ ez ⁇ ie b ⁇ li in g ⁇ udn ⁇ y ⁇ le ⁇ e, b ⁇ lshe s ⁇ ava ⁇ i vd ⁇ ⁇ e ⁇ bschaya slab ⁇ s ⁇ , g ⁇ l ⁇ v ⁇ uzhenie. Increased temperature. It becomes more painful for two weeks. After x-rays, metastases were found in the lungs, mediastinum and in the left cervical lymph node from an obscure focus.
  • the first stage consisted of three sessions at the choice of the non-resonant part from the range of 0.01–2.0 GHz from four generations
  • a, a 3 , dts, and 5 in parallel mode for at least 3 hours in each session daily with the subsequent rehabilitation and disinfection.
  • the first stage of the treatment was performed on the first scan of the two generators, and from the range of 8.0-18.0 GHz, it took eight hours every day for two days.
  • Example 3 Why welny, 79 years. Complaints of pain while swallowing, abundant salivation with frequent sticking with sticky meat, weakness, weakness, weak sleep.
  • Laryngoscopy data the pharynx is overexposed, the left side ligamentous tubercle is enlarged, the illogical ligaments are slightly narrowed, the lymph nodes are enlarged,
  • Laboratory research is taken from: research. generally mucous, general analysis of urine, urine. In the case of a large group of photographs after the occupation of the group, the defrosting of the wall of the group, the thickening of the overhead ligament. The diagnosis is a cancer of the city. Two stages of treatment were prescribed, each stage for every day, with an interval of seven days between them.
  • the RNG was emitted by using a program to select the non-resonant frequency from the range of 0.01-2.0 GHz in the second half of the day. This stage was carried out by the operation of two generators at a separate choice of the frequency from the 8.0-18 GHz band in the two-hour period. At the end of the course of treatment, there was a noticeable improvement in the general condition of the patient. painful sensations during swallowing decreased, lymph nodes in the left prudential region decreased to normal sizes. After a month, the second stage of irradiation was introduced. The overall success rate after treatment is satisfactory, pain and swallowing do not test salivation.
  • Example 4 Bolnoy ⁇ .. 35 years. Clinical diagnosis: total gastric lesion with metastases of the lymph nodes and liver. Like the body of the stomach ⁇ 4 ⁇ ⁇ 1. With an ultrasound scan. pancreas. X-rays of the lungs and the head of the pathology were not found.
  • the biopsy taken from the polip, located in the luminaire of the stomach with its external resemblance, corresponds to the transmissive non-carcinoma.
  • red blood cells - 4.2 color index - 0.95, heart rate - 325.0.
  • ⁇ lschina s ⁇ en ⁇ i zhelud ⁇ a decreased from 8.5 d ⁇ 2.44 - 3.36 cm ⁇ sche che ⁇ ez month was ⁇ v ⁇ ena ⁇ m ⁇ yu ⁇ e ⁇ naya ⁇ m ⁇ g ⁇ a ⁇ iya and ultrasound b ⁇ yushn ⁇ y ⁇ l ⁇ s ⁇ i: ⁇ echen not increased ⁇ dzhelud ⁇ chnaya iron ⁇ ch ⁇ i without ⁇ a ⁇ l ⁇ gii in leg ⁇ i ⁇ and g ⁇ l ⁇ ve me ⁇ as ⁇ az not ⁇ bna ⁇ uzhen ⁇ , ⁇ lschina s ⁇ en ⁇ i decreased 10 d ⁇ .
  • Example 5 Bolnoy X., 35 years. Complaints of weakness, shortness of breath, malaise, decreased workability. In the course of two years, it was treated better with herpes by antibiotic courses. The condition has improved, but after 1, 5 years, the above symptoms have appeared. The antibiotics were not indicated. Since both previous and previous treatment, the intestine was infused. There is no need to know anything about external factors. The patient was assigned treatment with the impact of the resonant frequencies of the RF radiation from the generators and the 8th operating in a parallel mode in the range of 6.0-18 GHz. There was an allotment of four sessions. A treatment session consisted of an irregular daily exposure for eight hours.
  • the composition of the hemoglobin at the end of the session was 120 g / l, after the sessions - 86 g / l. There was a slight decrease in the depth of the hemoglobin due to the residual foci of the herpes, localization of the blood cells was not detected. After a week, a direct analysis was performed - the parameters were restored, and the hemoglobin value was 140 g / l, which means that the value before the treatment started was increased.
  • Example 6 Man, 67 years old. I was struck by the big side of the bathtub; I felt severe pain in the area of injury in the area of the abdominal cavity, which is amplified by deep smoke. Cache. reading In the first place Respiration is frequent. There is a hematoma in the sixth area of the middle medullary line. The feeling of this place is painful. The X-ray pattern is visible in Part IV and V of the circle. The patient is given anesthesia by administration of 20.0 ml of 0.5% solution of novokaina. The fixed bandage is laid out. The pain syndrome in the following days did not disappear. Conventional physiotherapy is not indicated for the reason for the size of the mammary gland.
  • Example 7 Bolnoy ⁇ ., 38 years. I went to the clinic with a hospital in the living. ⁇ due to a malfunctioning initial treatment of patients with injuries at a hospital, the temperature was increased, acute pain was experienced in Rana, and there was a risk of loss of health in Ecuador. Separated from Rana has malicious stock.
  • Example 8 Sick ⁇ ., 55 years. Fifteen years of observation is required. There is a quicker exhaustion when wishing more than a hundred places. Intermittent weakness in the legs. the manifestation of pain in the muscles of the thigh, and the muscles of the back, the lumbar muscles. At EGH, the signs of rapid arrhythmia. Diagnosis: atherosclerosis of the lower extremities of the ST stage. The final appointment and the treatment phase.
  • the widespread use of the invention can increase the effectiveness of treatment and reduce the period of recovery of the sick. both in the early stage of the disease, and in the larger stage, as well as in the different types of the disease, viral and bacterial diseases, and ischemic diseases.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Cette invention se rapporte au domaine de la médecine, et concerne un dispositif à super-hautes fréquences qui permet de traiter des affections tumorales, virales et bactériennes ainsi que des blessures et des affections ischémiques. Ce dispositif comprend des antennes connectées en série à des générateurs de super-hautes fréquences, un ordinateur de définition de modes, et un dispositif de commande connecté aux générateurs de super-hautes fréquences. Chaque générateur possède une plage croissante par rapport au précédent, et peut fonctionner selon un mode série, parallèle, mixte ou de balayage. La plage de fréquence de rayonnement de tous les générateurs varie de 0,01 à 18,0 GHz. Cette invention concerne également des méthodologies de traitement. Grâce à l'action des fréquences générées par le dispositif et entrant en résonance par rapport aux jonctions quantiques des liaisons chimiques entre les biopolymères dans les tumeurs, les cellules pathologiques, les virus et les bactéries, on assiste à une destruction de ces liaisons qui entraîne la destruction des cellules malignes, des cellules pathologiques, des virus et des bactéries. Les cellules détruites sont extraites de l'organisme tout en effectuant une analyse du sang qui sert de procédé diagnostique. Le traitement est interrompu lorsque l'on assiste à une absence de dynamique de modification des paramètres sanguins. Cette invention permet d'accroître l'efficacité du traitement en évitant les effets secondaires.
PCT/RU2000/000047 1999-02-11 2000-02-11 Dispositif a rayonnement a super-hautes frequences et utilisation therapeutique de ce dispositif WO2000047280A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU31998/00A AU3199800A (en) 1999-02-11 2000-02-11 Super-high frequency radiation device and therapeutic use thereof

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
RU99102300 1999-02-11
RU99102300A RU2139114C1 (ru) 1999-02-11 1999-02-11 Устройство для лечения новообразований, вирусных и бактериальных заболеваний
RU99124908 1999-12-01
RU99124907 1999-12-01
RU99124908 1999-12-01
RU99124907 1999-12-01

Publications (1)

Publication Number Publication Date
WO2000047280A1 true WO2000047280A1 (fr) 2000-08-17

Family

ID=27354194

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/RU2000/000047 WO2000047280A1 (fr) 1999-02-11 2000-02-11 Dispositif a rayonnement a super-hautes frequences et utilisation therapeutique de ce dispositif

Country Status (2)

Country Link
AU (1) AU3199800A (fr)
WO (1) WO2000047280A1 (fr)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2033211C1 (ru) * 1993-09-17 1995-04-20 Даян Катипович Сафин Устройство для стимуляции и/или коррекции функционального состояния биологического объекта
RU2033210C1 (ru) * 1993-09-17 1995-04-20 Даян Катипович Сафин Устройство для стимуляции и/или коррекции функционального состояния биологического объекта
RU2068686C1 (ru) * 1993-02-05 1996-11-10 Фирма "Интерпром" Устройство для рефлекторной терапии
RU2078557C1 (ru) * 1993-02-08 1997-05-10 Кислов Владимир Яковлевич Способ рефлексотерапии и устройство для его осуществления
RU2113253C1 (ru) * 1995-09-12 1998-06-20 Товарищество с ограниченной ответственностью - Фирма "Новь" Устройство для электромагнитного воздействия на биообъект

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2068686C1 (ru) * 1993-02-05 1996-11-10 Фирма "Интерпром" Устройство для рефлекторной терапии
RU2078557C1 (ru) * 1993-02-08 1997-05-10 Кислов Владимир Яковлевич Способ рефлексотерапии и устройство для его осуществления
RU2033211C1 (ru) * 1993-09-17 1995-04-20 Даян Катипович Сафин Устройство для стимуляции и/или коррекции функционального состояния биологического объекта
RU2033210C1 (ru) * 1993-09-17 1995-04-20 Даян Катипович Сафин Устройство для стимуляции и/или коррекции функционального состояния биологического объекта
RU2113253C1 (ru) * 1995-09-12 1998-06-20 Товарищество с ограниченной ответственностью - Фирма "Новь" Устройство для электромагнитного воздействия на биообъект

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
I.G. AKOEV et al., Vliyanie dlitelnovo nizkointensivnovo vozdeistviya radiochastotnovo izlucheniya santimetrovovo diapazona na podkozhno privituyu adenokartsinomu Erlikha. Radiatsionnaya biologiya, Radioecologiya, M. NAUKA, 1995, Vol. 35, 1st edition, pages 23-27. *

Also Published As

Publication number Publication date
AU3199800A (en) 2000-08-29

Similar Documents

Publication Publication Date Title
Foley-Nolan et al. Pulsed high frequency (27MHz) electromagnetic therapy for persistent neck pain: a double blind, placebo-controlled study of 20 patients
US6701185B2 (en) Method and apparatus for electromagnetic stimulation of nerve, muscle, and body tissues
KR101134242B1 (ko) 생체전기자극, 치료가속화, 통증감소, 또는 병원체탈활화용 장치 및 방법
Li et al. Effectiveness of focused shockwave therapy versus radial shockwave therapy for noncalcific rotator cuff tendinopathies: a randomized clinical trial
US20030181949A1 (en) Medical therapy apparatus
Chen et al. Physical agent modalities
TW567078B (en) Electromagnetic apparatus of treatment of lesions associated with inadequate blood perfusion, partial denervation, tissue loss, pain, edema, inflammation and infection
Colson et al. Treatment of delayed-and non-union of fractures using pulsed electromagnetic fields
KR102465977B1 (ko) 전자기장 인가 장치
WO2000047280A1 (fr) Dispositif a rayonnement a super-hautes frequences et utilisation therapeutique de ce dispositif
RU161128U1 (ru) Аппарат физиотерапевтический глубокого теплового воздействия
Silantyeva The application of high intensity and low intensity magnetotherapy in rehabilitation of patients with COVID-19: a randomized controlled pilot study
WO2020172730A1 (fr) Dispositif pour le traitement de l'augmentation prostatique par utliisation d'un champ électromagnétique pulsé
Lightwood The remedial electromagnetic field
RU2459644C1 (ru) Способ лечения плоскоклеточного рака анального канала
RU2179465C1 (ru) Физиотерапевтическое устройство
RU2318551C1 (ru) Устройство электромагнитной терапии и способ электромагнитной терапии
RU2128984C1 (ru) Способ лечения янтарем и устройство для его осуществления "янтарная ванна"
RU2139114C1 (ru) Устройство для лечения новообразований, вирусных и бактериальных заболеваний
RU2657931C2 (ru) Способ лечения хронического простатита, ассоциированного с инфекциями, передаваемыми половым путем
RU2303976C1 (ru) Способ коррекции состояния больного бруцеллезом
RU2231376C1 (ru) Способ лечения хронического простатита в сочетании с доброкачественной гиперплазией предстательной железы
Null Biomagnetic healing
RU2156145C1 (ru) Способ лечения энуреза
Rizzo Magnetic Brain Pulses Relieve Many Ailments

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642